Barclays
INSP icon

Barclays’s Inspire Medical Systems INSP Stock Holding History

Barclays’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,700
Closed -$1.77M – 5268
2021
Q4 		$1.77M Buy
+7,700
New +$1.88M ﹤0.01% 2462

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays's INSP Position: Q2 2026 in Review

Barclays increased its Inspire Medical Systems (INSP) stake by 354% in Q2 2026, buying an estimated $11.4M and bringing the position to 307,270 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Barclays first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $15.9M in Q3 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Barclays held 307,270 shares of Inspire Medical Systems worth $13.7M as of Q2 2026.
  • Barclays bought 239,629 Inspire Medical Systems shares in Q2 2026, an estimated $11.4M.
  • Inspire Medical Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1324 holding.
  • Barclays first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
  • Barclays's Inspire Medical Systems position peaked at $15.9M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.